Step 1 topics → General Pharmacology → Antidote Quick Table (High-Yield)

Antidote Quick Table (High-Yield)

USMLE Step 1 trap: Misunderstands NAC as a direct NAPQI neutralizer rather than a glutathione precursor. NAC replenishes glutathione stores, which then conjugates and detoxifies NAPQI.

The antidote table is one of the most directly testable topics in all of pharmacology — if you know the pairings cold, you pick up points fast. USMLE Step 1 hits this from two directions: pure recall (what's the antidote for cyanide poisoning?) and clinical vignette application (a firefighter is pulled from a burning building, confused and hypotensive — what do you give?). The clinical vignettes are where students bleed points, because the toxin is often implied rather than named, and you have to recognize the toxidrome first before matching the antidote. The exam also loves to test whether you know not just what the antidote is, but how it works and when it's contraindicated — which is a much harder ask than simple recall.

The tricky part is that several antidotes have mechanisms that are counterintuitive or commonly misremembered. N-acetylcysteine is a classic example: students know it's used for acetaminophen toxicity but misremember it as directly neutralizing NAPQI, when it actually works upstream by replenishing glutathione. Similarly, organophosphate poisoning trips people up because there are two drugs required — atropine AND pralidoxime — and missing one is a common distractor. These aren't just trivia; the exam constructs wrong answer choices specifically around these partial understandings.

The other major trap is the contraindication category. Flumazenil for benzodiazepine overdose sounds right until you remember it can precipitate seizures in dependent patients or those with TCA co-ingestion. Digoxin toxicity management has its own landmine: giving calcium in the setting of digoxin-induced hyperkalemia can cause fatal arrhythmias ('stone heart'). USMLE Step 1 tests whether you know the full picture, not just the headline pairing. Build this table not as a list but as a set of mechanisms and caveats, and you'll be ready for whatever angle they throw at you.

From real student decks
81%have cards covering this topic
65%have mature cards

Common misconceptions

Common mistake
Wrong: N-acetylcysteine (NAC) works by directly neutralizing NAPQI in acetaminophen toxicity.
Right: NAC replenishes glutathione stores, which then conjugates and detoxifies NAPQI.
NAC does not directly bind or chemically neutralize NAPQI. Instead, NAC is a cysteine precursor that gets converted into glutathione inside hepatocytes. It's that newly synthesized glutathione that conjugates and detoxifies NAPQI. This distinction matters because it explains why timing is critical — if hepatocytes are already destroyed, there's no machinery left to convert NAC into glutathione.
Common mistake
Wrong: Atropine alone is sufficient to treat organophosphate poisoning.
Right: Atropine blocks muscarinic effects but pralidoxime (2-PAM) is also needed to reactivate acetylcholinesterase before 'aging' occurs.
Atropine blocks muscarinic receptors and controls the SLUDGE symptoms (salivation, lacrimation, urination, defecation, GI distress, emesis), but it does nothing to fix the underlying problem: acetylcholinesterase is still inhibited. Pralidoxime (2-PAM) actually reactivates acetylcholinesterase by cleaving the organophosphate bond — but only if given before 'aging' (irreversible bond maturation) occurs. You need both drugs; atropine alone is incomplete treatment.
Common mistake
Wrong: Flumazenil is safe to give to any patient with suspected benzodiazepine overdose.
Right: Flumazenil is contraindicated in patients with benzodiazepine dependence or co-ingestion of TCAs because it can precipitate seizures.
Flumazenil is a competitive benzodiazepine receptor antagonist, which sounds perfectly safe — but in a patient who is benzodiazepine-dependent, abruptly blocking those receptors precipitates acute withdrawal seizures. In TCA co-ingestion, benzodiazepines may be suppressing TCA-induced seizure activity, and reversing them removes that protection. The default clinical move in undifferentiated CNS depression is supportive care, not flumazenil.
Common mistake
Wrong: Digoxin toxicity is treated by increasing potassium to outcompete digoxin at the Na+/K+-ATPase.
Right: Digoxin toxicity is treated with anti-digoxin Fab antibody fragments, which directly bind and neutralize digoxin; hyperkalemia in digoxin toxicity should not be treated with calcium.
The correct antidote for digoxin toxicity is anti-digoxin Fab fragments, which bind free digoxin in plasma and pull it away from the Na+/K+-ATPase. While digoxin toxicity does cause hyperkalemia (by blocking the pump that drives K+ into cells), treating that hyperkalemia with calcium is dangerous — calcium potentiates digoxin's effect on cardiac conduction and can precipitate fatal arrhythmias, a phenomenon sometimes called 'stone heart.' Treat the digoxin with Fab, not the potassium with calcium.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recall the high-yield toxin-to-antidote pairings directly — you need to know antidotes for acetaminophen, digoxin, opioids, benzodiazepines, organophosphates, heavy metals, carbon monoxide, cyanide, methanol/ethylene glycol, heparin, warfarin, and beta-blockers without hesitation.
  2. Recognize common distractor traps in Step 1 antidote questions — such as choosing atropine alone for organophosphate poisoning (missing pralidoxime), giving flumazenil to a benzodiazepine-dependent patient, or treating digoxin toxicity hyperkalemia with calcium.

Can you avoid these mistakes?

A patient is brought in after ingesting an unknown substance. She has pinpoint pupils, respiratory depression, and bradycardia. You give naloxone and she improves briefly, then deteriorates again. What does this clinical course tell you about her overdose, and what is your next management step?
A mechanic is brought to the ED after accidentally spraying himself with a pesticide. He has excessive secretions, bronchospasm, miosis, and muscle fasciculations. You give atropine and his secretions improve, but he still has weakness and fasciculations. What is the explanation and what additional treatment is required?
A patient with chronic anxiety who takes clonazepam daily is found unresponsive after taking extra pills. A medical student suggests giving flumazenil. What is the risk of this plan, and what is the appropriate management instead?
An elderly patient on digoxin for atrial fibrillation develops nausea, visual changes (yellow halos), and a potassium of 5.8 mEq/L on labs. A colleague suggests giving IV calcium to protect the heart from hyperkalemia. Why is this approach dangerous, and what should you do instead?

Related topics

Acetaminophen Toxicity and NAC Digoxin Toxicity Sedative and Opioid Reversal Heavy Metal Poisoning and Chelators Toxic Alcohols and Gas Poisoning ADME and Bioavailability

See how your Anki deck covers this topic.

Upload your deck for a free audit →